What is the current Price Target for the Cstone Pharmaceuticals stock?

The average Cstone Pharmaceuticals target price is HK$17.24. This is 238.66% higher than the current stock price. The highest price target is 312.57%, the lowest is 95.45%. 5 Analysts have issued a price target Cstone Pharmaceuticals 2027 .

How high will the Cstone Pharmaceuticals stock rise?

No reliable answer can be given as to how high the Cstone Pharmaceuticals stock will rise. The performance of stocks, including the Cstone Pharmaceuticals stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cstone Pharmaceuticals stock today?

The performance of Cstone Pharmaceuticals stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cstone Pharmaceuticals stock fall?

The decline in Cstone Pharmaceuticals stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cstone Pharmaceuticals Forecast, price target & analysts

HK$5.09

2.96%

Hong Kong, Oct 09, 03:59 pm HKT. Closed.

ISIN

KYG2588M1006

Symbol

2616

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership Strategies

Cstone Pharmaceuticals Target price 2026 - Analyst rating & recommendation

Cstone Pharmaceuticals Classifications & Recommendation

Buy

89%

Hold

11%

Cstone Pharmaceuticals Price Target

Target Price	HK$17.24
Price	HK$5.09
Potential	238.66% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Cstone Pharmaceuticals 2027 . The average Cstone Pharmaceuticals target price is HK$17.24. This is 238.66% register free of charge higher than the current stock price. The highest price target is HK$21.00 312.57% register free of charge , the lowest is HK$9.95 95.45% register free of charge .
	A rating was issued by 9 analysts: 8 Analysts recommend Cstone Pharmaceuticals to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cstone Pharmaceuticals stock has an average upside potential 2027 of 238.66% register free of charge . Most analysts recommend the Cstone Pharmaceuticals stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Revenue Million HK$	316.14	580.25
	33.80%	83.54%
EBITDA Margin	-132.31%	-83.53%
	1,578.09%	36.87%

5 Analysts have issued a sales forecast Cstone Pharmaceuticals 2026 . The average Cstone Pharmaceuticals sales estimate is

unlock

. This is

unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics:

2025	HK$316m	33.80%
2026	HK$580m 83.54% unlock
2027	HK$2.4b 312.09% unlock
2028	HK$1.1b 52.16% unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share HK$	-0.37	0.04
	362.50%	110.81%
P/E		116.04
EV/Sales		13.06

5 Analysts have issued a Cstone Pharmaceuticals forecast for earnings per share. The average Cstone Pharmaceuticals EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	HK$-0.37	362.50%
2026	HK$0.04 110.81% unlock
2027	HK$0.69 1,625.00% unlock
2028	HK$-0.02 102.90% unlock

Current	-15.42	35.65%
2026	116.04 852.32% unlock
2027	7.34 93.67% unlock
2028	-319.23 4,449.18% unlock

Based on analysts' sales estimates for 2026, the Cstone Pharmaceuticals stock is valued at an EV/Sales of

unlock

and an P/S ratio of

unlock

This results in the following potential growth metrics and future valuations:

Current	15.20	68.77%
2026	13.06 14.09% unlock
2027	3.17 75.73% unlock
2028	6.62 109.05% unlock

Current	16.54	66.90%
2026	14.21 14.06% unlock
2027	3.45 75.73% unlock
2028	7.21 109.05% unlock

Cstone Pharmaceuticals...

Discover more stocks with a high price target

Alibaba Group Holding Ltd 77.47%

NIO ADR 75.94%

Rheinmetall 73.78%

Tencent Holdings Ltd. 59.92%

Infineon 56.83%

Adyen 51.95%

Deutsche Telekom 48.66%

TUI 47.34%

BYD 46.92%

Uber Technologies 44.06%

Siemens Energy 43.85%

NVIDIA 40.13%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now